• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

再次切除时,由于切缘接近或阳性,外阴残余癌及不典型增生的检出率低。

Low yield of residual vulvar carcinoma and dysplasia upon re-excision for close or positive margins.

机构信息

Washington University in St Louis School of Medicine, Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, 660 S. Euclid Ave, St Louis, MO 63110, USA.

出版信息

Gynecol Oncol. 2013 Jun;129(3):528-32. doi: 10.1016/j.ygyno.2013.02.033. Epub 2013 Mar 6.

DOI:10.1016/j.ygyno.2013.02.033
PMID:23474347
Abstract

OBJECTIVES

The objectives of this study are to determine the utility of re-excision after a primary diagnosis of vulvar carcinoma by assessing the frequency of residual carcinoma found upon re-excision and to quantitate the wound breakdown and carcinoma recurrence rates.

METHODS

We reviewed 1122 cases of VIN or vulvar carcinoma. Women who underwent re-excisional procedures, as part of their initial surgical treatment were identified. Associations between the margin status of the original excisional sample and histology of re-excision, as well as association between the depth of invasion upon initial excision and histology of re-excision were analyzed with Chi-square tests.

RESULTS

We identified 84 evaluable patients, 72 with stage I disease, 4 with stage II, and 7 with stage III disease. Upon the initial excisional procedure, 33 patients (39%) had carcinoma-positive margins, 27 patients had VIN-positive margins (32%) and 24 patients (28%) had negative margins (>1mm). Upon re-excision, 1/24 (4%) patients with negative margins, 2/27 (7%) patients with VIN-positive margins, and 11/33 (33%) patients with carcinoma-positive margins were found to have carcinoma in the re-excision specimens (p<0.0001, χ(2)=31). Deeper tumor invasion of the initial excisional specimen (1-12mm) was associated with a higher chance of finding carcinoma upon re-excision (range 18-42%, depending on depth of invasion) (p=0.015, χ(2)=19). Nineteen patients (23%) had vulvar wound breakdown post re-excision. Twelve patients (15%) experienced recurrences.

CONCLUSIONS

The yield of micro- or invasive carcinoma at re-excision is low, with a high wound breakdown rate. Re-excision should be considered for patients with margins positive for carcinoma, especially for women with deep invasion, while women with VIN or close but clear margins may be followed.

摘要

目的

本研究旨在通过评估再次切除时残留癌的检出率,以及量化伤口破裂和癌复发率,来确定外阴癌初次诊断后再次切除的效用。

方法

我们回顾了 1122 例 VIN 或外阴癌病例。确定了行再次切除手术的患者。采用卡方检验分析了初次切除标本的切缘状态与再次切除标本的组织学之间的关系,以及初次切除时的浸润深度与再次切除标本的组织学之间的关系。

结果

我们确定了 84 例可评估患者,72 例为 I 期疾病,4 例为 II 期疾病,7 例为 III 期疾病。初次切除时,33 例(39%)患者的切缘有癌阳性,27 例(32%)患者的切缘有 VIN 阳性,24 例(28%)患者的切缘为阴性(>1mm)。再次切除时,24 例(28%)阴性切缘患者中有 1 例(4%)、27 例(32%)VIN 阳性切缘患者中有 2 例(7%)、33 例(39%)癌阳性切缘患者中有 11 例(33%)在再次切除标本中发现癌(p<0.0001,卡方=31)。初次切除标本的肿瘤侵袭深度(1-12mm)越深,再次切除时发现癌的可能性越高(范围为 18-42%,取决于侵袭深度)(p=0.015,卡方=19)。19 例(23%)患者在再次切除后出现外阴伤口破裂。12 例(15%)患者出现复发。

结论

再次切除的微浸润或浸润性癌的检出率较低,但伤口破裂率较高。对于癌阳性切缘的患者,尤其是浸润较深的患者,应考虑再次切除,而对于 VIN 或切缘接近但清晰的患者,可以进行随访。

相似文献

1
Low yield of residual vulvar carcinoma and dysplasia upon re-excision for close or positive margins.再次切除时,由于切缘接近或阳性,外阴残余癌及不典型增生的检出率低。
Gynecol Oncol. 2013 Jun;129(3):528-32. doi: 10.1016/j.ygyno.2013.02.033. Epub 2013 Mar 6.
2
Impact of re-excision of residual adjacent vulvar intraepithelial neoplasia (VIN III) and histological tumour-free margin (hTFM) on survival in primary squamous cell carcinoma of vulva.外阴残余相邻上皮内瘤变(VIN III)再次切除及组织学切缘无肿瘤(hTFM)对外阴原发性鳞状细胞癌生存的影响。
Arch Gynecol Obstet. 2018 Nov;298(5):945-950. doi: 10.1007/s00404-018-4887-1. Epub 2018 Sep 6.
3
The outcomes of patients with positive margins after excision for intraepithelial Paget's disease of the vulva.外阴上皮内佩吉特病切除术后切缘阳性患者的结局。
Gynecol Oncol. 2007 Mar;104(3):547-50. doi: 10.1016/j.ygyno.2006.09.017. Epub 2006 Oct 24.
4
Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy.保乳治疗的早期乳腺癌患者行切除术活检后行再次切除术的最佳应用。
Ann Surg Oncol. 2009 Nov;16(11):3020-7. doi: 10.1245/s10434-009-0628-9. Epub 2009 Jul 28.
5
Role of adjuvant radiation or re-excision for early stage vulvar squamous cell carcinoma with positive or close surgical margins.早期外阴鳞状细胞癌切缘阳性或近切缘时辅助放疗或再次切除术的作用。
Gynecol Oncol. 2019 Aug;154(2):276-279. doi: 10.1016/j.ygyno.2019.05.028. Epub 2019 Jun 3.
6
Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma.外阴癌术后切缘状态与复发及放疗剂量的关系。
Gynecol Oncol. 2013 Sep;130(3):545-9. doi: 10.1016/j.ygyno.2013.05.036. Epub 2013 Jun 5.
7
Vulvar intraepithelial neoplasia III: occult cancer and the impact of margin status on recurrence.
Obstet Gynecol. 1998 Dec;92(6):962-6. doi: 10.1016/s0029-7844(98)00350-0.
8
Concordance of gross surgical and final fixed margins in vulvar intraepithelial neoplasia 3 and vulvar cancer.外阴上皮内瘤变3级及外阴癌手术切缘大体情况与最终固定切缘的一致性
J Reprod Med. 2006 Aug;51(8):617-20.
9
Vulvar intraepithelial neoplasia: Risk factors for recurrence.外阴上皮内瘤变:复发的危险因素。
Gynecol Oncol. 2018 Jan;148(1):126-131. doi: 10.1016/j.ygyno.2017.10.029. Epub 2017 Nov 7.
10
Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women.外阴上皮内瘤变:405例女性的自然史及转归情况
Obstet Gynecol. 2005 Dec;106(6):1319-26. doi: 10.1097/01.AOG.0000187301.76283.7f.

引用本文的文献

1
Comprehensive management of vulvovaginal cancers.外阴阴道癌的综合管理
CA Cancer J Clin. 2025 Sep-Oct;75(5):410-435. doi: 10.3322/caac.70014. Epub 2025 May 16.
2
Controversies in vulvar cancer: revisiting the margin of error.外阴癌的争议:重新审视误差范围。
Int J Gynecol Cancer. 2025 Mar;35(3):101678. doi: 10.1016/j.ijgc.2025.101678. Epub 2025 Jan 30.
3
VIN usual type-from the past to the future.外阴上皮内瘤变常见类型——从过去到未来。
Ecancermedicalscience. 2015 Apr 29;9:531. doi: 10.3332/ecancer.2015.531. eCollection 2015.